Related Experiment Video
Updated: Jul 9, 2026

Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus (MRSA)
Published on: February 9, 2011
Recognition and treatment of neonatal community-associated MRSA pneumonia and bacteremia
Stephanie Yee-Guardino1, Deepak Kumar, Nazha Abughali
1Department of Pediatrics, Section of Pediatric Infectious Diseases, Cleveland Clinic, 9500 Euclid Ave., Cleveland, Ohio 44195, USA.
Abstract:
Community-associated strains of methicillin-resistant Staphylococcus aureus (CA-MRSA) have recently emerged as a major cause of serious infections among older children and are now being seen in NICU patients. We present the case of a preterm infant with CA-MRSA necrotizing pneumonia and secondary bacteremia.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Mechanism of Antibiotic Resistance in MRSA
Acute Pyelonephritis II: Diagnostic Studies and Management
Bacterial Meningitis I: Introduction
Rocky Mountain Spotted Fever
